Description

TILAK VENTURES LIMITED has announced a rights issue offering 2 equity shares for every 1 share held at Re.1/- per share, with record date set for December 15, 2025.

Summary

TILAK VENTURES LIMITED (Scrip Code: 503663) has announced a rights issue of equity shares. The company will issue 2 (two) new equity shares of Re.1/- each for every 1 (one) existing equity share held by shareholders. The issue price is Re.1/- payable on application. Trading will commence on an ex-rights basis from December 15, 2025.

Key Points

  • Rights ratio: 2 new equity shares for every 1 existing share held
  • Issue price: Re.1/- per share (at par)
  • Face value: Re.1/- per equity share
  • Payment terms: Full issue price payable on application
  • Scrip code: 503663
  • Settlement: Dematerialized securities under rolling settlement segment

Regulatory Changes

No regulatory changes announced. This is a standard corporate action notification for a rights issue.

Compliance Requirements

  • Trading members must execute all transactions on an ex-rights basis from the specified date
  • Shareholders as of the record date will be eligible to participate in the rights issue
  • Trading members are required to take note of the ex-rights trading arrangement

Important Dates

  • Notice Date: December 10, 2025
  • Record Date: December 15, 2025
  • Ex-Rights Date: December 15, 2025
  • Settlement Number: DR-777/2025-2026

Impact Assessment

Shareholder Impact: Significant dilution event with a 2:1 rights ratio, effectively tripling the share capital if fully subscribed. Existing shareholders who do not participate will face substantial dilution of their ownership percentage.

Market Impact: Shares will trade ex-rights from December 15, 2025, likely resulting in a price adjustment to reflect the rights offering. The theoretical ex-rights price will be lower than the cum-rights price.

Trading Impact: All equity transactions in TILAK VENTURES LIMITED must be conducted on an ex-rights basis from December 15, 2025, affecting both institutional and retail trading activity.

Impact Justification

Rights issue represents significant dilution with 2:1 ratio but at nominal Re.1/- par value. Material corporate action for existing shareholders requiring immediate attention before ex-rights date.